Edwards Lifesciences Corp
EWNYSECIK 1099800HealthcareFiscal year ends Dec 31
Reports and events: 240 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-04-2616:29 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001099800-23-000019 |
| 2023-03-2816:16 ET | DEF 14A | Proxy statement | 0001099800-23-000013 |
| 2023-02-2116:30 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-23-043538 |
| 2023-02-1316:32 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001099800-23-000005 |
| 2023-01-3116:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001099800-23-000003 |
| 2022-12-0817:27 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-22-301136 |
| 2022-11-0109:13 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-274553 |
| 2022-10-2816:21 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001099800-22-000025 |
| 2022-10-2716:21 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001099800-22-000023 |
| 2022-07-2916:55 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001099800-22-000020 |
| 2022-07-2816:38 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001099800-22-000016 |
| 2022-07-2116:20 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-22-199173 |
| 2022-05-0417:19 ET | 8-K | 5.07 Shareholder vote results | 0001193125-22-140622 |
| 2022-04-2816:08 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001099800-22-000009 |
| 2022-04-2616:24 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001099800-22-000007 |
| 2022-03-2216:02 ET | DEF 14A | Proxy statementPeriod 2022-05-03 | 0001193125-22-081590 |
| 2022-02-1416:15 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001099800-22-000005 |
| 2022-01-2616:37 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001099800-22-000002 |
| 2021-10-2916:56 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001099800-21-000027 |
| 2021-10-2716:29 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001099800-21-000024 |
| 2021-07-3016:06 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001099800-21-000022 |
| 2021-07-2916:33 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001099800-21-000020 |
| 2021-07-1517:14 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-21-216533 |
| 2021-05-0516:56 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-21-151848 |
| 2021-04-2816:09 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001099800-21-000012 |
| 2021-04-2016:26 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001099800-21-000010 |
| 2021-03-2316:14 ET | DEF 14A | Proxy statementPeriod 2021-05-04 | 0001193125-21-091192 |
| 2021-02-1216:58 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001099800-21-000007 |
| 2021-01-2716:36 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001099800-21-000004 |
| 2020-10-2619:57 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001099800-20-000024 |
| 2020-10-2217:36 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001099800-20-000022 |
| 2020-07-2716:55 ET | 10-Q | Quarterly reportPeriod 2020-06-30 | 0001099800-20-000019 |
| 2020-07-2316:28 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001099800-20-000017 |
| 2020-07-1508:45 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-20-193022 |
| 2020-07-1316:16 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-20-191882 |
| 2020-05-0816:26 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-20-137597 |
| 2020-04-2819:56 ET | 10-Q | Quarterly reportPeriod 2020-03-31 | 0001099800-20-000009 |
| 2020-04-2316:23 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001099800-20-000007 |
| 2020-03-2516:16 ET | DEF 14A | Proxy statementPeriod 2020-05-07 | 0001193125-20-085079 |
| 2020-02-1416:13 ET | 10-K | Annual reportPeriod 2019-12-31 | 0001099800-20-000005 |
| 2020-01-3016:27 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001099800-20-000002 |
| 2019-10-2516:08 ET | 10-Q | Quarterly reportPeriod 2019-09-30 | 0001099800-19-000024 |
| 2019-10-2316:36 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001099800-19-000022 |
| 2019-07-2616:05 ET | 10-Q | Quarterly reportPeriod 2019-06-30 | 0001099800-19-000019 |
| 2019-07-2316:34 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001099800-19-000017 |
| 2019-05-0817:30 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events | 0001193125-19-141632 |
| 2019-04-2616:09 ET | 10-Q | Quarterly reportPeriod 2019-03-31 | 0001099800-19-000011 |
| 2019-04-2316:28 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001099800-19-000008 |
| 2019-03-2716:25 ET | DEF 14A | Proxy statementPeriod 2019-05-08 | 0001193125-19-088534 |
| 2019-02-1516:22 ET | 10-K | Annual reportPeriod 2018-12-31 | 0001099800-19-000004 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 15, 2026, 03:19 ET. Listed shows no prices and gives no investment advice.